No. Raloxifene is a Selective Estrogen Receptor Modulator (SERM). Bisphosphonate is a different drug category that is also used to prevent and treat postmenopausal osteoporosis.
Raloxifene therapy results in a better health profile than bisphosphonates. The risk of new osteoporotic fractures is also lesser than bisphosphonates.